首页 | 本学科首页   官方微博 | 高级检索  
检索        

恶性肉芽肿与中线淋巴瘤的临床观察
引用本文:熊金蓉,管竞贤.恶性肉芽肿与中线淋巴瘤的临床观察[J].中华放射肿瘤学杂志,1999,0(1):15-16.
作者姓名:熊金蓉  管竞贤
作者单位:中国人民解放军457医院肿瘤科(熊金蓉),同济医科大学附属同济医院肿瘤科(管竞贤)
摘    要:目的探讨恶性肉芽肿与中线淋巴瘤两种疾病的关系。方法自1989年12月至1995年3月共收治恶性肉芽肿及中线淋巴瘤各23例。两者在发病年龄、部位及首发症状相似。前者有73.9%单用放射治疗,后者有69.5%用放射治疗和化疗联合。病理类型前者为炎性坏死性肉芽组织,后者均为非霍奇金淋巴瘤(T细胞性13例,B细胞性1例,未分型9例)。结果完全缓解率分别为82.6%和65.2%,2年生存率分别为82.6%和73.9%。结论两者不应视为同一疾病。

关 键 词:恶性肉芽肿/放射疗法  淋巴瘤/放射疗法

Clinical radiotherapeutic differentiation of malignant granuloma and midline lymphoma
XIONG Jin rong ,GUAN Jingxian.Clinical radiotherapeutic differentiation of malignant granuloma and midline lymphoma[J].Chinese Journal of Radiation Oncology,1999,0(1):15-16.
Authors:XIONG Jin rong  GUAN Jingxian
Institution:XIONG Jin rong *,GUAN Jingxian. *The PLA 457 Hospital,Wuhan 430012
Abstract:Objective To differentiate malignant granuloma (MG) from midline lymphoma (ML) by radiotherapy.Methods From Dec. 1989 to Mar. 1995,23 cases of malignant granuloma and 23 cases of midline lymphoma were treated. These two kinds of disease were similar in the course, site and presenting symptoms. 73.9% patients with malignant granuloma were treated by radiotherapy alone, and 69.5% midline lymphoma patients were treated by combined radiotherapy and chemotherapy. Pathologically,the former was inflammatory necrotic granuloma and the latter was non Hodgkin's lymphoma (13 cases T cell,1 case B cell, and 9 cases unclassifiable).Results The complete response rates of MG and ML were 82.6 % and 65.2% respectively. Their 2 year survival rates were 82.6 % and 73.9% respectively.Conclusions Malignant granuloma and midline non Hodgkin's lymphoma should not be taken as one disease entity.
Keywords:Malignant granuloma/radiotherapy    Lymphoma/radiotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号